FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between DEE Piping Systems IPO and Emcure Pharma IPO.
DEE Piping Systems IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
DEE Piping Systems IPO | Emcure Pharma IPO | |
---|---|---|
Logo | ![]() |
![]() |
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | SBI Capital Markets Limited Equirus Capital Private Limited |
Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP ![]() |
DRHP ![]() |
RHP | RHP ![]() |
|
Anchor Investor | Anchor Investor ![]() |
|
IPO Allotment URL | IPO Allotment URL ![]() |
The total issue size of DEE Piping Systems IPO is up to ₹418.01 Cr whereas the issue size of the Emcure Pharma IPO is . The final issue price of DEE Piping Systems IPO is ₹203.00 per share and of Emcure Pharma IPO is .
DEE Piping Systems IPO | Emcure Pharma IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹193.00 per share | |
Issue Price (Upper) | ₹203.00 per share | |
Issue Price (Final) | ₹203.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ₹19.00 per share | |
Market Lot Size | 73 shares | |
Fresh Issue Size | 1,60,09,852 shares | |
Fresh Issue Size (Amount) | up to ₹325.00 Cr | up to ₹800.00 Cr |
OFS Issue Size | 45,82,000 shares | 1,36,78,839 shares |
OFS Issue Size (Amount) | up to ₹93.01 Cr | |
Issue Size Total | 2,05,91,852 shares | |
Issue Size Total (Amount) | up to ₹418.01 Cr |
DEE Piping Systems IPO opens on Jun 19, 2024, while Emcure Pharma IPO opens on . The closing date of DEE Piping Systems IPO and Emcure Pharma IPO is Jun 21, 2024, and , respectively.
DEE Piping Systems IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Bid Date | Jun 18, 2024 | |
Issue Open | Jun 19, 2024 | |
Issue Close | Jun 21, 2024 | |
Basis Of Allotment (Tentative) | Jun 24, 2024 | |
Initiation of Refunds (Tentative) | Jun 25, 2024 | |
Credit of Share (Tentative) | Jun 25, 2024 | |
Listing date (Tentative) | Jun 26, 2024 | |
Anchor Lockin End date 1 | Jul 24, 2024 | |
Anchor Lockin End date 2 | Sep 22, 2024 |
DEE Piping Systems IPO P/E ratio is 83, as compared to Emcure Pharma IPO P/E ratio of .
DEE Piping Systems IPO | Emcure Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | DEE Development Engineers Limited Financial Information (Restated Consolidated)DEE Development Engineers Limited's revenue increased by 30.47% and profit after tax (PAT) rose by 58.25% between the financial year ending with March 31, 2023 and March 31, 2022.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹1401.69 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 3.91%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 3.35%% |
In the DEE Piping Systems IPO retail investors (RII) are offered 71,89,907 shares while in Emcure Pharma IPO retail investors are offered 71,89,907 shares. Qualified institutional buyers (QIB) are offered 41,08,518 shares in DEE Piping Systems IPO and in Emcure Pharma IPO.
DEE Piping Systems IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | 61,62,777 shares | |
Market Maker Reserveration | ||
QIB | 41,08,518 shares | |
NII | 30,81,389 shares | |
RII | 71,89,907 shares | |
Employee | 0 shares | |
Others | ||
Total | 1,43,79,814 shares |
DEE Piping Systems IPO subscribed 103.03x in total, whereas Emcure Pharma IPO subscribed .
DEE Piping Systems IPO | Emcure Pharma IPO | |
---|---|---|
QIB (times) | 206.54x | |
NII (times) | 149.38x | |
Big NII (times) | 165.71x | |
Small NII (times) | 116.73x | |
RII (times) | 23.66x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 103.03x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|